IVDs Conference - SAN DIEGO, June 29, 2012 /PRNewswire/ --
IVD Technology Magazine announces the Evolution of Advanced IVDs Conference on September 19-20, 2012 at the San Diego Convention Center. This one-of-a-kind event addresses all the key regulatory, business and technical challenges of the niche IVD industry. "The IVD sector is under more systemic pressure than ever. The industry's ability to understand, innovate and market to key clinical needs will determine the success with which our industry can re-assert, and be recognized for, its immense value to the global healthcare system," states Jon Vance of MedDx Capital Advisors, advisory board member and speaker at the inaugural event. Jon will be leading a panel discussion on the recent trends in capital markets and how to determine the best funding strategy for an IVD startup. Other panelists include Peter Klemm, CEO at Applied Proteomics and Marty Waters, Partner at Wilson Sonsini.
The comprehensive two-day program promises to serve as an ideal setting for major players, IVD entrepreneurs and industry experts to network face-to-face and discuss timely and effective practical strategies and solutions for IVD companies. The agenda includes segments on regulatory landscape, commercialization and growth opportunities, latest developments in IVD technology, and a special feature on companion diagnostics.
Opening the regulatory segment, Don St.Pierre, Deputy Director for New Product Evaluation in the Office of In Vitro Diagnostics at the FDA will be remotely presenting on submissions in 510(k), PMA, and de novo classifications as well as addressing concerns for longer review times and guidance documents. In the technology segment, presentations on the latest in sequencing, molecular diagnostics, assays and point of care devices will be delivered by top speakers from Amgen, Roche, Gen-Probe, Ambry Genetics, and Alere.
Please visit http://www.ivdtconference.com to see the full program, speaker line-up and to register. Early bird discount pricing ends August 8th.
About IVD Technology
IVD Technology is the only trade journal designed exclusively for manufacturers of in vitro diagnostic products. Written by leading experts in their fields, IVDT's peer-reviewed articles cover a wide range of technical, business, and regulatory topics. The publication's primary focus is on diagnostics technologies - including research, development, and manufacturing.
IVDT articles contain authoritative information on all aspects of manufacturing immunoassays, nucleic-acid-based diagnostics, clinical chemistry tests, and related instrumentation. Regular editorial coverage offers insights into the implications of new and pending regulations, the behind-the-scenes workings of the regulatory process, and the legal issues affecting product development and marketing. IVDT also analyzes critical business and marketing issues such as product liability, emerging markets, and other key trends. For more information, please visit http://www.ivdtechnology.com
For sponsorship opportunities, please contact Christine Nguyen, Sponsorship Manager at (310) 996-9445 or [email protected]
For more information on Evolution of Advanced IVDs and related conferences, please contact Nicole Maisner, Marketing Manager at +1-310-996-9416 or [email protected]
SOURCE UBM Canon